D. Hay

发表

International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor

Takao Shimizu, Jilly F. Evans, Takehiko Yokomizo, 2004, Pharmacological Reviews.

Saccharomyces cerevisiae telomerase is an Sm small nuclear ribonucleoprotein particle

H. Sarau, J. Foley, N. Aiyar, 1999 .

Postulated Mechanisms Underlying Airway Hyperreactivity

D. Hay, 1989 .

Evidence for Alpha7 Nicotinic Receptor Activation During the Cough Suppressing Effects Induced by Nicotine and Identification of ATA-101 as a Potential Novel Therapy for the Treatment of Chronic Cough

R. DeVita, P. Dicpinigaitis, B. Canning, 2021, The Journal of Pharmacology and Experimental Therapeutics.

SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung.

John C. Lee, J. Adams, J. Adams, 2000, American journal of physiology. Lung cellular and molecular physiology.

KCL CONTRACTIONS IN THE RAT INTACT AND BISECTED VAS DEFERENS: CONTRIBUTION OF ENDOGENOUS NORADRENALINE RELEASE

R. Wadsworth, D. Hay, D. Hay, 1983, Clinical and experimental pharmacology & physiology.

Airway epithelium-derived inhibitory factor.

S. G. Farmer, D. Hay, L. Fernandes, 1990, TIPS - Trends in Pharmacological Sciences.

International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors

Jilly F. Evans, J. Drazen, S. Dahlén, 2003, Pharmacological Reviews.

SmithKline Beecham Pharmaceuticals’ cysteinyl leukotriene receptor antagonists: Pranlukast (SB 205312; Ono-1078; Onon), Pobilukast (SK&F 104353) and SK&F 106203

D. Hay, 1999 .

Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways.

R. Hall, K. A. Wilson, J. Gleason, 1987, The Journal of pharmacology and experimental therapeutics.

Mechanism of endothelin‐induced contraction in guinea‐pig trachea: comparison with rat aorta

D. Hay, 1990, British journal of pharmacology.

Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction In vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists.

R. Panettieri, D. Hay, E. Tan, 1998, American journal of respiratory cell and molecular biology.

Chronic obstructive pulmonary disease: emerging therapies.

D. Hay, 2000, Current opinion in chemical biology.

Chapter 11. Current and Potential New Therapies for Chronic Obstructive Pulmonary Disease

D. Hay, M. Barnette, 1999 .

Expression and Function of Voltage-dependent Potassium Channel Genes in Human Airway Smooth Muscle*

B. Freedman, B. Fleischmann, M. Kotlikoff, 1996, The Journal of Biological Chemistry.

The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo

Takao Shimizu, Charles N. Serhan, G. Enrico Rovati, 2006, Pharmacological Reviews.

Recognition and inactivation of LPS by lipophorin particles.

S. Asgari, G. Ma, D. Hay, 2006, Developmental and comparative immunology.

5 – Inhibitors of Fatty Acid-Derived Mediators

D. Hay, D. Griswold, 1994 .

The Preclinical and Clinical Pharmacology of SK&F 104353, a Potent and Selective Peptidoleukotriene Receptor Antagonist

R. Hall, J. Gleason, T. Torphy, 1991, Annals of the New York Academy of Sciences.

Endothelin and the respiratory system.

P. Henry, D. Hay, R. Goldie, 1993, Trends in pharmacological sciences.

Molecular and pharmacological characterization of the murine tachykinin NK(3) receptor.

H. Sarau, R. Ames, J. Foley, 2001, European journal of pharmacology.

Food Restriction–Mediated Adrenal Influences on Antigen–Induced Bronchoconstriction and Airway Eosinophil Influx in the Guinea Pig

D. Underwood, R. Osborn, D. Hay, 1998, International Archives of Allergy and Immunology.

Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth-muscle cells. Modulation by cyclic adenosine monophosphate.

A. Ammit, R. Panettieri, R. Penn, 2000, American journal of respiratory cell and molecular biology.

Tumor Necrosis Factor-a – Induced Secretion of RANTES and Interleukin-6 from Human Airway Smooth-Muscle Cells Modulation by Cyclic Adenosine Monophosphate

A. Ammit, R. Panettieri, R. Penn, 2000 .

Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody.

D. Underwood, R. Osborn, T. Torphy, 1996, American journal of respiratory and critical care medicine.

Endothelin‐1‐induced potentiation of human airway smooth muscle proliferation: an ETA receptor‐mediated phenomenon

P. Rigby, A. Eszterhas, R. Panettieri, 1996, British journal of pharmacology.

Involvement of cysteinyl leukotrienes in airway smooth muscle cell DNA synthesis after repeated allergen exposure in sensitized Brown Norway rats

D. A. Walsh, P. Barnes, M. Salmon, 1999, British journal of pharmacology.

Phosphodiesterase IV inhibitors as therapy for eosinophil-induced lung injury in asthma.

D. Underwood, T. Torphy, D. Hay, 1994, Environmental health perspectives.

Pharmacologic and pharmacokinetic profile of SK&F S-106203, a potent, orally active peptidoleukotriene receptor antagonist, in guinea-pig.

H. Sarau, J. Gleason, R. Osborn, 1991, Pulmonary pharmacology.

In vitro and in vivo pharmacological profile of PL-3994, a novel cyclic peptide (Hept-cyclo(Cys-His-Phe-d-Ala-Gly-Arg-d-Nle-Asp-Arg-Ile-Ser-Cys)-Tyr-[Arg mimetic]-NH(2)) natriuretic peptide receptor-A agonist that is resistant to neutral endopeptidase and acts as a bronchodilator.

P. Cooper, R. Panettieri, J. Edelson, 2013, Pulmonary Pharmacology & Therapeutics.

A novel role for tachykinin neurokinin-3 receptors in regulation of human bronchial Ganglia neurons.

D. Hay, R. Goldie, A. Myers, 2005, American journal of respiratory and critical care medicine.

Cysteinyl Leukotriene Receptor Assays

R. Muccitelli, D. Hay, M. Luttmann, 2000, Current protocols in pharmacology.

Endothelin‐induced contraction and mediator release in human bronchus

W. Hubbard, B. Undem, D. Hay, 1993, British journal of pharmacology.

Relative contributions of direct and indirect mechanisms mediating endothelin‐induced contraction of guinea‐pig trachea

W. Hubbard, B. Undem, D. Hay, 1993, British journal of pharmacology.

Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs.

H. Sarau, J. Foley, F. Barone, 2002, The Journal of pharmacology and experimental therapeutics.

The antitussive activity of delta-opioid receptor stimulation in guinea pigs.

D. Underwood, G. Dondio, P. Petrillo, 2000, The Journal of pharmacology and experimental therapeutics.

Is endothelin-1 a mediator in asthma?

P. Henry, D. Hay, R. Goldie, 1996, American journal of respiratory and critical care medicine.

The bronchopulmonary pharmacology of SK&F 104353 in anesthetized guinea pigs: demonstration of potent and selective antagonism of responses to peptidoleukotrienes.

D. Underwood, R. Osborn, T. Torphy, 1989, The Journal of pharmacology and experimental therapeutics.

Is the guinea pig trachea a good in vitro model of human large and central airways? Comparison on leukotriene-, methacholine-, histamine- and antigen-induced contractions.

T. Torphy, M. Wasserman, R. Muccitelli, 1987, The Journal of pharmacology and experimental therapeutics.

DIFFERENCES IN TIME-RELATED CARDIOPULMONARY RESPONSES TO HYPOXIA IN THREE RAT STRAINS

D. Underwood, R. Osborn, C. Louden, 2000, Clinical and experimental hypertension.

PUTATIVE MEDIATOR ROLE OF ENDOTHELIN‐1 IN ASTHMA AND OTHER LUNG DISEASES

D. Hay, Dwp Hay, 1999, Clinical and experimental pharmacology & physiology.

Endothelin as a Proinflammatory Mediator

J. Filep, D. Hay, 1999 .

Endothelin-1 receptor density, distribution, and function in human isolated asthmatic airways.

P. Henry, D. Hay, R. Goldie, 1995, American journal of respiratory and critical care medicine.

Chronic Models of Arthritis in the Rabbit Antagonist of CXCR2 Inhibits Acute and A Potent and Selective Nonpeptide

H. Sarau, J. Foley, L. Marshall, 2013 .

A Potent and Selective Nonpeptide Antagonist of CXCR2 Inhibits Acute and Chronic Models of Arthritis in the Rabbit1

H. Sarau, J. Foley, L. Marshall, 2002, The Journal of Immunology.

Interleukin-8 receptor antagonists in pulmonary diseases.

H. Sarau, D. Hay, 2001, Current opinion in pharmacology.

Human urotensin‐II is a potent spasmogen of primate airway smooth muscle

S. Douglas, D. Hay, M. Luttmann, 2000, British journal of pharmacology.

2-Phenyl-4-quinolinecarboxamides: a novel class of potent and selective non-peptide competitive antagonists for the human neurokinin-3 receptor.

H. Sarau, J. Foley, A. Medhurst, 1996, Journal of medicinal chemistry.

Endothelin receptors and calcium translocation pathways in human airways

R. Muccitelli, D. Hay, R. Goldie, 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.

D. Underwood, R. Osborn, T. Torphy, 1994, The Journal of pharmacology and experimental therapeutics.

Is the epithelium-derived inhibitory factor in guinea-pig trachea a prostanoid?

R. Muccitelli, D. Hay, D. Raeburn, 1988, Prostaglandins.

Airway epithelium modulates the reactivity of guinea-pig respiratory smooth muscle.

J. Fedan, S. G. Farmer, D. Hay, 1986, European journal of pharmacology.

The effects of epithelium removal on the sensitivity of guinea‐pig isolated trachealis to bronchodilator drugs

J. Fedan, S. G. Farmer, D. Hay, 1986, British journal of pharmacology.

Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle.

B. Undem, T. Torphy, M. L. Reeves, 1993, The Journal of pharmacology and experimental therapeutics.

Effects of intranasal administration of endothelin-1 to allergic and nonallergic individuals.

D. Proud, D. Hay, M. M. Riccio, 1995, American journal of respiratory and critical care medicine.

Guinea-pig tracheal epithelium and endothelin.

D. Hay, 1989, European journal of pharmacology.

Chronic hypoxia-induced cardiopulmonary changes in three rat strains: inhibition by the endothelin receptor antagonist SB 217242.

E. Ohlstein, D. Underwood, R. Osborn, 1998, Journal of cardiovascular pharmacology.

Differential effects of epithelium removal on the responsiveness of guinea‐pig tracheal smooth muscle to bronchoconstrictors

K. A. Wilson, R. Muccitelli, J. Fedan, 1987, British journal of pharmacology.

Relaxation of guinea‐pig tracheal smooth muscle to arachidonate is converted to contraction following epithelium removal

J. Fedan, S. G. Farmer, D. Hay, 1987, British journal of pharmacology.

Epithelium modulates the reactivity of ovalbumin-sensitized guinea-pig airway smooth muscle.

J. Fedan, S. G. Farmer, D. Hay, 1986, Life sciences.

Epithelium removal increases the reactivity of human isolated tracheal muscle to methacholine and reduces the effect of verapamil.

J. Fedan, S. G. Farmer, D. Hay, 1986, European journal of pharmacology.

The effect of verapamil is reduced in isolated airway smooth muscle preparations lacking the epithelium.

J. Fedan, S. G. Farmer, D. Hay, 1986, Life sciences.

Hypoxia-induced pulmonary hypertension in an optimized environment for the guineapig

D. Underwood, R. Osborn, D. Hay, 1997, Laboratory animals.

The effects of calcium channel inhibitors on twitches and noradrenaline contractions of the rat bisected vas deferens.

R. Wadsworth, D. Hay, 1983, European journal of pharmacology.

THE CONTRACTILE EFFECTS OF 5‐HYDROXYTRYPTAMINE ON THE RAT ISOLATED VAS DEFERENS

R. Wadsworth, D. Hay, R. Wadsworth, 1982, British journal of pharmacology.

Effect of verapamil on rhythmic contractions in isolated rat vasa deferentia [proceedings].

R. Wadsworth, D. Hay, 1980, British journal of pharmacology.

Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist.

H. Sarau, J. Foley, F. Barone, 2000, The Journal of pharmacology and experimental therapeutics.

Evidence that the proposed novel human "neurokinin-4" receptor is pharmacologically similar to the human neurokinin-3 receptor but is not of human origin.

D. Y. Wang, H. Sarau, J. Foley, 2000, Molecular pharmacology.

Investigation of SAR requirements of SR 142801 through an indexed combinatorial library in solution

M. Artico, D. Graziani, D. Hay, 1999 .

In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity.

H. Sarau, J. Foley, S. Van Horn, 1999, Prostaglandins, leukotrienes, and essential fatty acids.

Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonists.

H. Sarau, S. Gagliardi, M. Artico, 1999, Farmaco.

Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 1. Identification of the 4-quinolinecarboxamide framework.

H. Sarau, A. Medhurst, C. Farina, 1997, Journal of medicinal chemistry.

Differential antagonism of airway contractile responses to prostaglandin (PG)D2 and 9 alpha, 11 beta-PGF2 by atropine, SK&F 88046 and SQ 29,548 in the guinea pig.

D. Underwood, T. Torphy, M. Wasserman, 1994, The Journal of pharmacology and experimental therapeutics.

The development of tone in the smooth muscle of guinea-pig isolated tracheal preparations may be influenced by prostanoids released from the adjacent airway cartilage.

R. Muccitelli, J. Fedan, D. Hay, 1987, Prostaglandins.

Demonstration of the release of an epithelium-derived inhibitory factor from a novel preparation of guinea-pig trachea.

K. A. Wilson, R. Muccitelli, D. Hay, 1987, European journal of pharmacology.

Differential modulation of endothelin ligand‐induced contraction in isolated tracheae from endothelin B (ETB) receptor knockout mice

Z. Ao, S. Douglas, P. Rigby, 2001, British journal of pharmacology.

Endothelins in the Lung

P. Henry, D. Hay, R. Goldie, 1998 .

Comparison ofendothelin B(ETB) receptors inrabbit isolated pulmonary artery andbronchus

D. Hay, G. Beck, M. Luttmann, 1996 .

Cellular mechanisms of endothelin in rabbit aorta.

E. Ohlstein, D. Hay, S. Horohonich, 1989, The Journal of pharmacology and experimental therapeutics.

Subcellular localization of leukotriene D4 receptors in sheep tracheal smooth muscle.

S. Crooke, D. Hay, S. Mong, 1988, Molecular pharmacology.

SK&F 104353, a selective leukotriene receptor antagonist, inhibits leukotriene D4- and antigen-induced bronchoconstriction in cynomolgus monkeys.

R. Osborn, T. Torphy, M. Wasserman, 1992, Pulmonary pharmacology.

Role of phosphatidylinositol turnover in the contraction of the rat aorta.

E. Motley, D. Hay, A. Nichols, 1991, Advances in experimental medicine and biology.

erratum: Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

H. Sarau, R. Ames, J. Foley, 1999, Nature.

Functional antagonism by salbutamol suggests differences in the relative efficacies and dissociation constants of the peptidoleukotrienes in guinea pig trachea.

K. A. Wilson, T. Torphy, M. Wasserman, 1988, The Journal of pharmacology and experimental therapeutics.

Airway epithelial modulation of smooth-muscle function : the evidence for epithelium-derived inhibitory factor

S. G. Farmer, D. Hay, 1991 .

An overview of species differences in the effects of a water extract of cotton bract on isolated airway smooth muscle, and effects of E. coli lipopolysaccharide.

J. Fedan, D. Hay, K. Weber, 1986, Environmental health perspectives.

Epithelium-Dependent Responsiveness of Airway Smooth Muscle: The role of Epithelium-Derived Relaxant Factors

P. Barnes, M. Grunstein, A. Leff, 1997 .

Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412).

H. Sarau, J. Foley, A. Medhurst, 1999, Journal of medicinal chemistry.

The effect of inhibitors of prostaglandin formation on contraction of the rat, rabbit and human vas deferens.

R. Wadsworth, D. Hay, I. J. Zeitlin, 1990, Journal of autonomic pharmacology.

EFFECTS OF SOME ORGANIC CALCIUM ANTAGONISTS AND OTHER PROCEDURES AFFECTING Ca2+ TRANSLOCATION ON KCl‐INDUCED CONTRACTIONS IN THE RAT VAS DEFERENS

R. Wadsworth, D. Hay, 1982, British journal of pharmacology.

Leukotriene receptors (version 2020.3) in the IUPHAR/BPS Guide to Pharmacology Database

Jilly F. Evans, J. Drazen, S. Dahlén, 2020 .

Leukotriene receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

Jilly F. Evans, J. Drazen, S. Dahlén, 2019, IUPHAR/BPS Guide to Pharmacology CITE.

Calcium uptake into guinea-pig trachealis: the effect of epithelium removal.

J. Fedan, D. Hay, D. Raeburn, 1987, Cell calcium.

The effects of calcium channel inhibitors and other procedures affecting calcium translocation on drug‐induced rhythmic contractions in the rat vas deferens

R. Wadsworth, D. Hay, R. Wadsworth, 1983, British journal of pharmacology.

Nonpeptide tachykinin receptor antagonists: I. Pharmacological and pharmacokinetic characterization of SB 223412, a novel, potent and selective neurokinin-3 receptor antagonist.

H. Sarau, J. Foley, N. Elshourbagy, 1997, The Journal of pharmacology and experimental therapeutics.

In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non‐peptide NK3 receptor antagonists

A. A. Parsons, A. Medhurst, D. Hay, 1997, British journal of pharmacology.

Characterization of NK3 receptors in rabbit isolated iris sphincter muscle

A. A. Parsons, A. Medhurst, D. Hay, 1997, British journal of pharmacology.

Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases

H. Sarau, J. Foley, W. Rumsey, 2013, The Journal of Pharmacology and Experimental Therapeutics.

Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor.

J. Chambers, H. Sarau, R. Ames, 1999, Molecular pharmacology.

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

H. Sarau, R. Ames, J. Foley, 1999, Nature.

SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence.

R R Osborn, D E Griswold, J. Adams, 2000, The Journal of pharmacology and experimental therapeutics.

Role of neurokinin receptors in the behavioral effect of intravesical antigen infusion in guinea pig bladder.

J. Hieble, D. Hay, M. Ruggieri, 2000, The Journal of urology.

The endothelins in the pulmonary system.

M. Carr, P. Henry, D. Hay, 1996, Pulmonary pharmacology.

Local anaesthetic activity of organic calcium antagonists: relevance to their actions on smooth muscle.

R. Wadsworth, D. Hay, 1982, European journal of pharmacology.

Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonist.

J. D. Elliott, J. Luengo, D. Brooks, 1998, The Journal of pharmacology and experimental therapeutics.

Pharmacology of leukotriene receptor antagonists. More than inhibitors of bronchoconstriction.

D. Hay, 1997, Chest.

Endothelin receptor subtypes in human and guinea‐pig pulmonary tissues

W. Hubbard, B. Undem, D. Hay, 1993, British journal of pharmacology.

A Highly Convergent Synthesis of 2‐Phenyl Quinoline as Dual Antagonists for NK2 and NK3 Receptors

Zehong Wan, K. Ward, H. Sarau, 2005 .

Cysteinyl leukotrienes in asthma: old mediators up to new tricks.

B. Undem, T. Torphy, D. Hay, 1995, Trends in pharmacological sciences.

Polymorphisms in the endothelin-1 (EDN1) are associated with asthma in two populations

A. Roses, M. Barnes, P. Helms, 2008, Genes and Immunity.

Regional differences in reactivity and in the influence of the epithelium on canine intrapulmonary bronchial smooth muscle responsiveness.

J. Fedan, D. Hay, D. Raeburn, 1987, European journal of pharmacology.

Pulmonary Actions of the Endothelins

D. Hay, R. Goldie, 1998, Respiratory Pharmacology and Pharmacotherapy.

Nonpeptide endothelin receptor antagonists. X. Inhibition of endothelin-1- and hypoxia-induced pulmonary pressor responses in the guinea pig by the endothelin receptor antagonist, SB 217242.

D. Underwood, R. Osborn, D. Hay, 1997, The Journal of pharmacology and experimental therapeutics.

Receptors for endothelin‐1 in asthmatic human peripheral lung

P. Henry, A. D'Aprile, D. Hay, 1995, British journal of pharmacology.

Nonpeptide endothelin receptor antagonists. VIII: attentuation of acute hypoxia-induced pulmonary hypertension in the dog.

R. Willette, E. Ohlstein, D. Hay, 1997, The Journal of pharmacology and experimental therapeutics.

Endothelin B receptor modulates inflammatory pain and cutaneous inflammation.

Z. Ao, S. Douglas, E. Ohlstein, 1999, Molecular pharmacology.

Correlation between airway epithelium‐induced relaxation of rat aorta in the co‐axial bioassay and cyclic nucleotide levels

D. Spina, R. Muccitelli, D. Hay, 1992, British journal of pharmacology.

Effects of methoxamine and barium on 45Ca2+ fluxes in the rat vas deferens.

R. Wadsworth, D. Hay, 1992, European journal of pharmacology.

Effects of KCl on 45Ca uptake and efflux in the rat vas deferens

D. Hay, R. Wadsworth, 1984, British journal of pharmacology.

Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists.

F E Blaney, H. Sarau, F. Blaney, 2001, Journal of medicinal chemistry.

Nonpeptide endothelin receptor antagonists. IX. Characterization of endothelin receptors in guinea pig bronchus with SB 209670 and other endothelin receptor antagonists.

D. Hay, M. Luttmann, Douglas W. P. Hay, 1997, The Journal of pharmacology and experimental therapeutics.

Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus

D. Hay, G. Beck, M. Luttmann, 1996, British journal of pharmacology.

Potential pathophysiological role of endothelin-1 in asthma.

D. Hay, R. Goldie, 1998, Drug news & perspectives.

Pharmacological evidence for distinct endothelin receptors in guinea‐pig bronchus and aorta

D. Hay, 1992, British journal of pharmacology.

Functional and binding characterization of endothelin receptors in human bronchus: evidence for a novel endothelin B receptor subtype?

P. Nambi, D. Hay, M. Pullen, 1998, The Journal of pharmacology and experimental therapeutics.

Leukotriene receptors in GtoPdb v.2023.1 Leukotriene receptors in GtoPdb v.2023.1

J. Drazen, S. Dahlén, C. Serhan, 2023 .

Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB 207499 (Ariflo) in the guinea pig.

S. Christensen, D. Underwood, R. Osborn, 1998, The Journal of pharmacology and experimental therapeutics.

The dependence of airway smooth muscle on extracellular Ca2+ for contraction is influenced by the presence of cartilage.

J. Fedan, D. Hay, I. Rodger, 1986, Life sciences.

Inflammatory mediators and modulation of epithelial/smooth muscle interactions

S. G. Farmer, D. Hay, R. Goldie, 1994 .

Pharmacologic profile of SK&F 104353, a novel, highly potent and selective peptidoleukotriene antagonist.

R. Hall, K. Erhard, K. A. Wilson, 1987, Advances in prostaglandin, thromboxane, and leukotriene research.

Relative contributions of direct and indirect mechanisms mediating endothelin-induced contraction of guinea-pig trachea.

W. Hubbard, B. Undem, D. Hay, 1993, British journal of pharmacology.

The airway epithelium : physiology, pathophysiology, and pharmacology

S. G. Farmer, D. Hay, 1991 .

Evidence that epithelium‐dependent relaxation of vascular smooth muscle detected by co‐axial bioassays is not attributable to hypoxia

D. Spina, R. Muccitelli, D. Hay, 1992, British journal of pharmacology.

Targeted disruption of the endothelin-B-receptor gene attenuates inflammatory nociception and cutaneous inflammation in mice.

Z. Ao, S. Douglas, E. Ohlstein, 2000, Journal of cardiovascular pharmacology.